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ABSTRACT
Background. To compare the demographic and clinical 
characteristics of children with newly clinically diag-
nosed type 1 diabetes (T1DM) who presented with 
diabetic ketoacidosis (DKA) versus non DKA presenta-
tion and to identify the precipitating factor(s) related 
to progression to DKA.
Methods. Over a 3 month period, 99 patients newly 
diagnosed with T1DM were recruited from Diabetes, 
Endocrine and Metabolism Pediatric Unit (DEMPU), 
Cairo University, with 53 patients presented with DKA 
and 46 were non DKA.
Results. Polyuria, polydipsia, weight loss, polyphagia 
and nocturia were the most common symptoms pre-
ceding the diagnosis among the whole study group 
(93.8%, 92% and 80.8%, 76.8%, 46.5 % respectively) 
with no difference between DKA and non DKA groups. 
Delayed diagnosis occurred in 98.1% and 58.7% of DKA 
and non DKA groups respectively. In the DKA group 
the diagnosis of diabetes was missed in 69.8% and in 
28.3% the initiation of insulin therapy was delayed 
despite diagnosis.
Multivariate analysis performed to identify the most 
significant precipitating factor(s) associated with the 
development of DKA at diabetes diagnosis showed 
that delayed start of insulin therapy was the most 
significant factor (OR = 1.267, P value = 0.023).
Conclusion. The prevalence of DKA is high among Egyp-
tian children at diagnosis of type 1 diabetes. It is not 
only caused by misdiagnosis and mismanagement of 
diabetes, but also delayed initiation of insulin therapy 
in those diagnosed. This highlights the importance of 
increasing awareness concerning clinical features of 
diabetes in children and the urgency of insulin therapy 
among primary health care professionals and the com-
munity. (Clin Diabet 2020; 9; 5: 286–292)
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Introduction
The epidemiologic features of type 1 diabetes mel-
litus (T1DM) and thus DKA are continuously changing. 
The worldwide incidence of the disease has increased, 
the reasons for this are yet unknown. Non genetic, 
environmental causes are incriminated in the rapid 
rise of the disease incidence [1]. Egypt is one of the 
countries of the Middle East and North Africa (MENA) 
region. According to International Diabetes Federation 
(IDF) report of 2019, the number of children and adoles-
cents (less than 19 years old) with type 1 diabetes was 
149,400 cases in MENA region. The number of newly 
diagnosed patients was 20,800 annually according to 
the same report [2]. In Egypt, the prevalence of type 1 
diabetes estimates in 1992 was 8.0 cases/100,000 [3]. 
Another study in 2005 revealed the overall incidence 
was 3.5/100,000 and the estimated prevalence of 
type 1 diabetes was 38/100,000 [4]. A more recent 
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epidemiological study for prevalence of type 1 diabetes 
in Egyptian subpopulation living in Nile Delta (North 
Egypt) between 1994 and 2011 was 1.9/100,000 in 
1994 reised to 26.8/100000 in 2011 [5]. The incidence 
and prevalence of type 1 diabetes in Egypt must have 
been considerably changed although there is lack of 
nationwide diabetes registry. 
Diabetic ketoacidosis (DKA) is an acute life threat-
ening complication of type 1 diabetes and fundamental 
cause of morbidity and mortality among children with 
type 1 diabetes as well as s extra healthcare expenses 
[6, 7].
Most of DKA episodes are theoretically preventable 
through early diagnosis of diabetes and proper insulin 
management [1], yet to date, DKA frequency at diagno-
sis of type 1 diabetes in children is still undetermined. 
Previous report from 24 centers in Europe collected as 
part of the EURODIAB revealed variable frequency of 
DKA at diagnosis of type 1 diabetes ranged from 11% 
to 67% [8]. Incidence and rate of complications of DKA 
and its treatment are largely dependent on various 
parameters including T1DM incidence in a certain area, 
age of the child, and access to healthcare facilities for 
the patients and their families [9].
Previous reports from Egypt regarding frequency of 
DKA at diagnosis of type 1 diabetes revealed variable 
rates ranging from 18.6 to 80%, most of these studies 
are retrospective and cross sectional single center ex-
periences [10–12]. Another recent study recorded DKA 
as the first presentation in 71% of toddler at the initial 
diagnosis of type 1 diabetes [13]. The development 
of DKA at the diagnosis of type 1 diabetes is associa - 
ted with poor outcome in the form of more future 
psychological disorders, less rates of partial remission, 
and excess healthcare expenses [6]. More understand-
ing of the frequency and the risk factors related to the 
development of DKA at the time of T1DM diagnosis in 
children can provide a guide for proper interventional 
steps for decreasing DKA episodes and consequently 
healthcare improvement for better patients outcome 
and lower healthcare expenditures. Thus we aimed 
to describe and compare the demographic and clini-
cal characteristics of children with newly diagnosed 
type 1 diabetes who presented with DKA versus those 
who presented with hyperglycemia (non DKA) and to 
identify the precipitating factor(s) related to progres-
sion to DKA.
Methods
This is a prospective study was conducted over 3 
months period from May to August 2016 at the Diabe-
tes Endocrine and Metabolism Pediatric Unit (DEMPU) 
at the Children’s hospital of Cairo University. The study 
included all children younger than 15 years of age who 
were presenting with newly clinically diagnosed type 1 
diabetes, and were admitted for management during 
the study period either in the DEMPU ICU if ketoacidosis 
or in the inpatient ward if non DKA (hyperglycemia with 
or without ketonuria). The diagnosis of T1D and DKA 
were made according to the International Society of 
Pediatric and Adolescent Diabetes consensus guidelines 
[14]. After consent, parents were asked to provide more 
detailed information than that is regularly requested 
on admission records at DEMPU.
Requested information was collected from all the 
patients’ parents/guardians by the same investigator, 
and included: chronological age, residence area, num-
ber of siblings and order of child within siblings, family 
history of diabetes including age at onset and mode 
of therapy in 1st, 2nd and 3rd degree relatives, avail-
ability of previous knowledge about diabetes, preced-
ing symptoms and their duration before diagnosis of 
diabetes, possible precipitating factors, history of any 
misdiagnoses, timing of the start of insulin therapy and 
history of any mismanagement after being diagnosed 
with diabetes (diet planning alone, exercise with diet 
panning, oral hypoglycemic drugs etc.), and availability 
of health insurance coverage.
The study protocol was approved by the local re-
search ethics committee of the pediatric department 
at Cairo University. 
Statistical methods 
The data were processed and analyzed with SPSS 
15.0 statistical package software (SPSS Inc., Chicago, 
Illinois, USA). Qualitative variables were shown as 
numbers and percentages and quantitative variables 
were demonstrated as means ± SD. The chi-square 
test and Fisher’s exact test were used to compare the 
qualitative data. The differences between quantitative 
groups with normal distribution were evaluated with 
student’s t-test or the analysis of variance. The differ-
ences between quantitative groups with abnormal 
distribution were evaluated with either Mann-Whitney 
U test or Kruskal-Wallis test. A P value of ≤ 0.05 was 
considered as statistically significant. Multivariate 
analysis was done to predict the most significant risk 
factor(s) associated with the development of DKA at 
the time of diabetes diagnosis.
Results 
Over the 3 months study period, a total of 99 
patients with newly diagnosed type 1 diabetes were 
included; 53 (24 females and 29 males) presented with 
DKA with variable severity and 46 (23 females and 23 
males) with non DKA presentation. Twenty-six patients 
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presented with severe DKA (representing 46% of the 
DKA group and 26% of the total number of patients 
as a whole). Only 9 patients (9%) of the whole study 
group presented with hyperglycemia without ketonuria 
or ketosis.
Positive parental consanguinity was found in 25 
(25.3%) patients among the whole studied groups. 
Positive family history of diabetes was detected in 54 
(54.5%) patients among the whole recruited groups. 
There was significantly higher number of patients with 
first degree relative with diabetes among DKA group 
(P value = 0.005). Comparison between DKA and 
non DKA groups revealed no significant difference as 
regards sex, mean (± SD) chronological age at presenta-
tion, residence area, parental consanguinity, birth order 
in the family, number of siblings in the family, family 
history of diabetes, type of diabetes in the family, and 
availability of health insurance coverage. As regards 
previous knowledge about diabetes, the majority of the 
patients’ guardians in both groups had no clear know-
ledge about diabetes (symptoms and management), 
with no statistically significant difference between the 
two groups, Table 1.
The most common symptoms preceding the 
diagnosis were polyuria, polydipsia, weight loss, poly-
phagia and nocturia among the two studied groups. 
Additionally, DKA group had obvious typical symptoms 
suspecting DKA diagnosis (vomiting, abdominal pain, 
weakness, disturbed conscious level, respiratory distress 
and dehydration) (Fig. 1).
Delayed diagnosis (was defined as > 72 h between 
the recognition of symptoms and diagnosis of diabe-
tes) was recorded in 98.1% and 58.7% of DKA and 
non DKA groups respectively, and was significantly 
higher in DKA group (P = 0.014). Misdiagnosis was 
reported in 69.8% of the DKA group as respiratory 
problems (30.2%), gastroenteritis (26.4%) and urinary 
tract infections (1.9%). Mismanagement in the form 
of delayed initiation of insulin therapy after diabetes 
diagnosis was recorded in 15 patients (28.3%) of the 
DKA group versus only one patient (2.2%) in non DKA 
group with statistically significant difference between 
Table 1. Comparison of the demographic data of the two studied groups (DKA and non DKA), total = 99 patients with 
newly diagnosed type 1 diabetes
DKA group (n = 53)  
(53.5%)




Female 24 (45.3%) 23 (50%) 0.659
Male 29 (54.7%) 23 (50%)
Chronological age (years)
Mean ± SD (range) 6.89 ± 3.63 (1.0–14.0) 6.75 ± 3.54 (2.0–13.0) > 0.05
Residence
Rural 11 (20.8%) 8 (17.4%) 0.835
Urban 10 (18.9%) 11 (23.9%)
Slum 32 (60.4%) 27 (58.7%)
Positive parental consanguinity 12 (22.6%) 13 (28.3%0 0.634
Order of child in the family
1st 16 (30.2%) 18 (39.1%) 0.335
2nd 17 (32.1%) 17 (37%)
≥ 3rd 20 (37.7%) 11 (23.9%)
Number of siblings in family
1 2 (3.8%) 3 (6.5%) 0.078
2 11 (20.8%) 9 (19.6%)
≥ 3 40 (75.4%) 34 (73.9%)
Positive family history of diabetes 30 (56.6%) 24 (52.2%) 0.489
Health insurance Availability 29 (54.7%) 24 (52.2%) 0.814
Previous knowledge about diabetes 14 (26.4%) 15 (32.6%) 0.092
First degree family member with diabetes
Yes 23 (43.4%) 8 (17.4%) 0.005
No 30 (56.6%) 38 (82.6%)
DKA — diabetic ketoacidosis
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the two groups (P value = 0.003) (Fig. 2). Forms of 
mismanagement included prescribing diet modification 
(amount and type) only, diet modification and exercise, 
diet modification with abstinence from sugar and/or 
oral hypoglycemic drugs. Logistic regression analysis 
to identify the most significant risk factor(s) associated 
with the development of DKA in children with newly 
diagnosed type 1 diabetes showed delayed start of 
insulin therapy as the most significant risk factor with 
(OR = 1.267, P = 0.023) (Table 2).
Discussion
The frequency of DKA at the onset of diabetes in 
children varies considerably from country to country. 
This short term prospective study aimed to investigate 
the frequency and risk factors associated with the de-
velopment of diabetic ketoacidosis in Egyptian infants 
and children below 15 years of age with new onset 
type 1 diabetes. The frequency of DKA at presentation 
was 53.5%, with nearly half of the cases with severe 
DKA (severe DKA in 49%, moderate DKA in 45.3%, and 
mild DKA in 5.7%). The same high frequency was also 
reported by a previous study [12] from the same center 
which was 51.5% among children with newly diag-
nosed diabetes. Additionally, an earlier study conducted 
in another tertiary referral center in Egypt reported the 
frequency of DKA at T1DM diagnosis was 60.57% [15]. 
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Figure 2. Precipitating factors for DKA development. P value less than 0.05 is significant
Figure 1. The common presenting symptoms in diabetic ketoacidosis group (DKA) and non DKA group. DCL — disturbed con-
scious level; RD — respiratory distress
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of DKA at the time of type 1 diabetes diagnosis among 
Egyptian children.
The frequency of DKA at the onset of type 1 diabetes 
from different countries other than Egypt ranged from 
12.8% to 80% with the highest frequency in Saudi Arabia 
and United Arab Emirates. However, the lowest incidence 
was reported in Canada and Sweden [6]. Mbugua et al. 
[16] suggested the explanation for the different preva-
lence rates includes differences in study population, the 
background prevalence of diabetes in the given popula-
tion, presence or absence of family history of T1DM, as 
well as the definition of DKA used in the particular study.
In agreement with previous reports [12, 17] the 
most common symptoms preceding the diagnosis 
were polyuria, polydipsia, weight loss, polyphagia and 
nocturia among the two studied groups. However, the 
incidence of infection and febrile illness were signifi-
cantly higher among the ketoacidosis group. This was 
in agreement with the results of Xin et al. [18] and 
Rayfield et al. [19] who also reported that history of 
infection could increase the danger of development 
of diabetic ketoacidosis and explained that the cause 
could be attributed to insulin resistance that result from 
the release of inflammatory cytokines and the counter 
regulatory response, also the infection itself could mask 
the early symptoms of diabetes.
 Misdiagnosis was reported in about 70% of DKA 
group. Most of the patients were misdiagnosed as 
respiratory problems or gastroenteritis. Misdiagnosis 
also can lead to delayed diagnosis. 
Delayed diagnosis in the present study was defined 
as more than 72 h between recognition of symptoms 
and diagnosis of diabetes. This was significantly more 
frequent among the DKA group when compared to the 
non DKA group. We assume that one of the contribut-
ing factors to the delay in diagnosis was the high rate 
of occurrence of infection at diabetes presentation, 
which deviated the management to the apparent 
infection without suspecting diabetes. This confirms 
the necessity of raising the awareness regarding the 
presenting clinical features of diabetes in children as 
well as stressing on the importance of blood glucose 
assessment in any unwell child. 
Delayed diagnosis was also previously reported 
by Sundaram et al. [20] in the UK who found that 
more than 24 hour delay in the diagnosis of diabetes 
symptoms can increase the diabetic ketoacidosis risk 
presentation. However, a systematic review conducted 
by Uscher-Smith et al. [21] found that delayed diagno-
sis itself as a risk factor for DKA presentation was not 
consistent among the studies. 
Mismanagement with delayed start of insulin 
therapy after diabetes diagnosis was detected in 
28.3% of the DKA group versus only one patient in 
non DKA group, with statistically significant difference 
between the two groups. Mismanagement after being 
diagnosed with diabetes included one of the following 
measures: diet modification alone, exercise with diet 
modification, abstinence from sugar with or without 
added oral hypoglycemic drugs. Although initiation of 
insulin therapy immediately after T1DM diagnosis is the 
mainstay treatment. Refusal of insulin as the primary 
line of treatment is a major problem among Egyptian 
families. Insulin is usually perceived as terminal meas-
ure in the treatment plan of diabetes. Also there is a 
misconception almost always expressed by the parents 
that insulin injection will suppress the endogenous pan-
creatic secretion and hinder the recovery of pancreatic 
cells. In addition, the belief that diabetes in children is 
essentially caused by factors like psychological stress 
or overconsumption of sweets and sugary food make 
parents persuading measures of intervention other than 
the start of insulin injections. 
Multivariate analysis to determine the most signifi-
cant precipitating factor(s) associated with the develop-
ment of DKA at the time of diabetes diagnosis revealed 
that delayed initiation of insulin therapy, in spite of 
diagnosis of diabetes was the most significant risk factor 
associated with development of DKA (OR = 1.267, P value 
= 0.023). Lévy-Marchal et al. [8] reported in a multicentre 
study across Europe that the delay more than 24 hours 
between diagnosis and treatment was associated with 
a small increased risk of developing diabetic ketoacidosis 
among children (odds ratio 1.74 [1.10 to 2.77]).
Other studied factors, age at onset of diabetes and 
time lapse between onset of diabetes symptoms and 
Table 2. Logistic regression analysis for variables predicting the development of DKA at diagnosis of diabetes
Risk factors for developing DKA Odds ratio 95% CL for OR P value
Upper Lower
Chronological age (years) 0.962 1.043 0.887 0.343
Time lapse between onset of symptoms and diagnosis of diabetes (hours) 0.992 1.011 0.973 0.407
Time lapse between diagnosis of diabetes and start of insulin treatment (hours) 1.267 1.552 1.034 0.023
DKA — diabetic ketoacidosis
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diagnosis of diabetes were statistically comparable. 
Residence area (urban, slum or rural), and parental 
consanguinity also didn’t reach statistically significant 
difference between the two groups. This is in agree-
ment with other previous studies [21, 22]. 
Concerning consanguinity, 25.5% of all patients 
were offspring of consanguineous parents but there 
was no significant difference between the two groups 
regarding parental consanguinity. This finding was 
concordant to what was reported by Usher-Smith et al. 
[21] in their systematic review who found that parental 
consanguinity failed to show a significant difference 
in the rate of diabetic ketoacidosis in children of con-
sanguineous parents.
The present study also showed that positive family 
history of diabetes was found in 54.5% of all patients, 
56.6% of them presented with DKA with significantly 
higher number of first degree relative with diabetes 
among this group. The majority of cases had relatives 
with type 2 diabetes. The present study revealed that 
the presence of positive family history of diabetes, 
unfortunately, was not protective and did not prevent 
progression to DKA by recognizing symptoms at earlier 
stage. This might indicate low awareness of clinical 
features and treatment of diabetes in children as well 
as the refusal of the families with a positive family his-
tory of diabetes to accept the reality that children are 
susceptible to develop diabetes. 
Awareness should clearly target the necessity of 
the immediate initiation of insulin therapy once dia-
betes is diagnosed in the pediatric age group, and the 
high risk of ketoacidosis if delayed. This should target 
health care professionals as well as the community as 
a whole as apparently acceptance of insulin therapy 
is commonly rejected and feared by parents, and not 
always perceived as urgent by health care professionals.
Conclusion 
The prevalence of DKA is high among Egyptian 
children at diagnosis of type 1 diabetes. It is not only 
caused by misdiagnosis and mismanagement of dia-
betes, but also delayed initiation of insulin therapy in 
those diagnosed. This highlights the importance of 
increasing awareness concerning clinical features of 
diabetes in children and the urgency of insulin therapy 
among primary health care professionals and the com-
munity as a whole.
Limitation 
Our study had some limitations, the small sample 
size and the short period of assessment (3 months). 
Further detailed analysis of patients according to dif-
ferent age groups could not be done due to small 
sample size. Further larger and multicenter studies are 
needed to answer that unanswered question whether 
DKA is a result of an aggressive disease form or it is 
a result of delayed diagnosis and delayed initiation of 
insulin therapy. 
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